Today's Stocks Driving Success For The Health Services Industry

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 73 points (0.5%) at 14,495 as of Friday, March 22, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,725 issues advancing vs. 1,132 declining with 170 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is up 0.6%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.9%, Fresenius Medical Care Corporation ( FMS), up 1.2% and Covidien ( COV), up 0.5%. On the negative front, top decliners within the industry include Agilent Technologies ( A), down 1.3%, Express Scripts ( ESRX), down 0.9% and Thermo Fisher Scientific ( TMO), down 0.6%.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today:

5. Zimmer Holdings ( ZMH) is one of the companies pushing the Health Services industry higher today. As of noon trading, Zimmer Holdings is up $0.59 (0.8%) to $72.97 on light volume Thus far, 339,514 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $72.35-$73.20 after having opened the day at $72.56 as compared to the previous trading day's close of $72.38.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $12.4 billion and is part of the health care sector. Currently there are 12 analysts that rate Zimmer Holdings a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Zimmer Holdings Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

4. As of noon trading, Becton Dickinson ( BDX) is up $0.53 (0.6%) to $92.46 on light volume Thus far, 300,982 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $91.91-$92.78 after having opened the day at $92.19 as compared to the previous trading day's close of $91.93.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $18.0 billion and is part of the health care sector. The company has a P/E ratio of 16.9, below the S&P 500 P/E ratio of 17.7. Shares are up 17.6% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Becton Dickinson a buy, 5 analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Becton Dickinson Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

3. As of noon trading, Boston Scientific ( BSX) is up $0.08 (1.0%) to $7.44 on light volume Thus far, 5.7 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 20.4 million shares. The stock has ranged in price between $7.35-$7.48 after having opened the day at $7.38 as compared to the previous trading day's close of $7.37.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $10.1 billion and is part of the health care sector. Shares are up 28.6% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. Get the full Boston Scientific Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, HCA Holdings ( HCA) is up $0.89 (2.3%) to $39.45 on average volume Thus far, 1.7 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $38.70-$39.66 after having opened the day at $38.76 as compared to the previous trading day's close of $38.56.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $17.2 billion and is part of the health care sector. The company has a P/E ratio of 11.0, below the S&P 500 P/E ratio of 17.7. Shares are up 27.8% year to date as of the close of trading on Thursday. Currently there are 17 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, weak operating cash flow and poor profit margins. Get the full HCA Holdings Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, Baxter International ( BAX) is up $0.67 (1.0%) to $70.73 on average volume Thus far, 1.2 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $69.89-$70.95 after having opened the day at $70.25 as compared to the previous trading day's close of $70.06.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $38.2 billion and is part of the health care sector. The company has a P/E ratio of 16.7, below the S&P 500 P/E ratio of 17.7. Shares are up 5.1% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Baxter International Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
null

If you liked this article you might like

Zimmer Biomet's Prognosis Is Promising

Zimmer Biomet's Prognosis Is Promising

St. Jude Buying Thoratec Could Resusitate Medtech M&As

St. Jude Buying Thoratec Could Resusitate Medtech M&As

Analysts' Actions -- AT&T, Fitbit, Netflix and More

Analysts' Actions -- AT&T, Fitbit, Netflix and More

Barbarian At The Gate: Zimmer Holdings (ZMH)

Barbarian At The Gate: Zimmer Holdings (ZMH)

Deal Delay Minor Obstacle for Zimmer

Deal Delay Minor Obstacle for Zimmer